FSHR and pancreatic neuroendocrine tumor: FSHR is reported to be aberrantly expressed in the endothelial cells of tumors affecting various organs including prostate, breast, colon, pancreas, urinary bladder, kidney, lung, liver, stomach, testis, and ovary [74] and pancreatic neuroendocrine tumors [75].